Public health reports from poison control center calls and emergency department visits, as well as circulating media reports, indicate an increase in adverse health events from synthetic cannabinoids throughout the country. Legal action varies in effectiveness to ban these products and discontinue sales. Increasing reports of clusters of cannabinoid related health effects and statewide marijuana legalization on the horizon highlight the importance of utilizing syndromic surveillance to monitor and characterize morbidity associated with these products.
Authors own copyright of their articles appearing in the Online Journal of Public Health Informatics. Readers may copy articles without permission of the copyright owner(s), as long as the author and OJPHI are acknowledged in the copy and the copy is used for educational, not-for-profit purposes. Share-alike: when posting copies or adaptations of the work, release the work under the same license as the original. For any other use of articles, please contact the copyright owner. The journal/publisher is not responsible for subsequent uses of the work, including uses infringing the above license. It is the author's responsibility to bring an infringement action if so desired by the author.